louisiana glp-1 gi obstruction class action semaglutide louisiana bowel obstruction class action Louisiana Diabetes Drugs & Gastrointestinal Injuries louisiana glp-1 gastric intestinal obstruction

doi: 10.1016/j.biomaterials.2014.07.026

Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: a meta-analysis

Characterizations of this state of metabolic crisis have distinguished low fuel (ischemic) states from conditions in which metabolic substrates are available but not effectively utilized (mitochondrial dysfunction)

About 1 in 8 adults are now taking a GLP-1 drug for obesity, disease, or both, up 6 percentage points from May 2024, according to KFF poll results released in November

Martyn JAJ, & Richtsfeld M (2006): Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms